Kennedy Research Group
Kennedy Research Group
High Field Magnetic Resonance Laboratory
Department of Chemistry and Biochemistry
Miami University
graduate student group
May, 2023
Ruojing Zhang, Michael C. Stahr, Michael A. Kennedy
Introduction of a new scheme for classifying beta-turns in protein structures
Proteins: Structure, Function and Bioinformatics, 2021. https://doi.org/10.1002/prot.26190
Shenyuan Xu, Kristen Rose McGinnis, Yang Liu, Pengwei Huang, Ming Tan, Michael Robert Stuckert, Riley Erin Burnside, Elsa Grace Jacob, Shuisong Ni, Xi Jiang, Michael A. Kennedy
Structural basis of P[II] rotavirus evolution and host ranges under selection of histo-blood group antigens
PNAS September 7, 2021 118 (36) e2107963118; https://doi.org/10.1073/pnas.2107963118
Recent News
March 30, 2021 - Congratulations to Ruojing Zhang who successfully defended her PhD dissertation entitled "THE INVESTIGATION OF BIOPHYSICAL AND BIOLOGICAL FUNCTION OF PENTAPEPTIDE REPEAT PROTEINS FROM NOSTOC PCC 7120."
October 27, 2020 - On October 27, 2020, Dr. Kennedy received a U.S. Patent entitled "Engineered Oncolytic Viruses Containing Hyper-Binding Sites To Sequester And Suppress Activity Of Oncogenic Transcription Factors As A Novel Treatment For Human Cancer", Patent No: US 10,813,957 B2
November 15, 2019 - Congratulations to William Joesten who successfully defended his PhD dissertation entitled "EXPLORING THE RELATIONSHIPS BETWEEN GUT BACTERIA, GUT PERMEABILITY, AND BACTERIAL METABOLISM IN THE NON OBESE DIABETIC (NOD) MOUSE MODEL OF TYPE 1 DIABETES (T1D)" on November 15, 2019.
July 30, 2019 - Congratulations to Irina Petrova who successfully defended her Masters Thesis entitled INFLUENCE OF DRYING METHOD ON NMR-BASED METABOLIC PROFILING OF HUMAN CELL LINES on July 30, 2019.
April 23, 2018 - Congratulations to Michelle Schmahl who successfully defended her PhD dissertation entitled " METABOLIC PROFILING OF URINE, FECAL, AND SERUM SAMPLES AND PANCREATIC TUMORS AND EVALUATION OF HMGA1 EXPRESSION LEVELS IN PANCREATIC INTRAEPITHELIAL NEOPLASIA CELLS IN THE PTF1A-CRE; LSL-KRASG12D TRANSGENIC MOUSE MODEL OF PANCREATIC CANCER" on April 10, 2018.
November 21, 2017 - Congratulations to Tafadzwa Chihanga who received her PhD entitled “USE OF NMR-BASED METABONOMICS TO STUDY HUMAN DISEASE IN MOUSE MODELS AND CANCER CELL LINES” on November 21, 2017.
November 17, 2017 - Congratulations to Faizule Hassan who defended his PhD entitled "ADENOVIRUS MEDIATED DELIVERY OF DECOY HYPER BINDING SITES FOR SEQUESTRATION OF AN ONCOGENIC TRANSCRIPTION FACTOR HMGA AS A POTENTIAL NOVEL CANCER THERAPY AND ANTIBACTERIAL ACTIVITY OF LOCAL MUSHROOMS" on November 17, 2017.
August 11, 2017 - Congratulations to Shenyuan Xu who received his PhD entitled "NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY STUDIES OF AT2G44920, A PENTAPEPTIDE REPEAT PROTEIN FROM ARABIDOPSIS THALIANA AND X-RAY CRYSTALLOGRAPHY, ISOTHERMAL TITRATION CALORIMETRY STUDIES OF K-RAS, A HUMAN ONCOGENIC GTP-ASE SIGNALING PROTEIN" on August 11 and attended the hooding ceremony. Shen will be staying on in the lab as a postdoc.
August 2, 2017 - Kennedy Group launches the MOUSE MODEL OF PANCREATIC CANCER ATLAS (MMPCA) - AN ONLINE RESOURCE FOR RESEARCHERS AND PATHOLOGISTS WHO WORK IN THE FIELD OF PANCREATIC CANCER. The MMPCA can be found at https://mousepancreaticcancer.wordpress.com/category/welcome/. The manuscript introducing the MMPCA was published in PLoS-ONE and can be found at http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187552. The research was performed by graduate student Michelle Veite-Schmahl and a team of undergraduate students.
January 12, 2016: On January 12, 2016, Dr. Kennedy received at U.S. Patent entitled "Use of HMGA-Targeted Aptamers to Suppress Carcinogenic Activity and Increase Sensitivity to Chemotherapy in Human Cancer Cells", Patent No: US 9,233,119 B2